Inflammation

PARK CITY, Utah — Outcomes from the phase 1/2a HORNBILL study indicate a potential disease-modifying effect of BI 764524 in eyes with diabetic macular ischemia.

CHICAGO — An hourlong session at NUTRITION spotlighted several studies that investigated different approaches to enhancing exercise performance by manipulating diet and nutrition.

Persistent higher or moderate-to-increasing inflammation that begins in early adulthood may result in worsening midlife executive function and processing speed, according to data published in Neurology.

A dexamethasone 0.4 mg intracanalicular insert was linked to greater improvement in corneal and conjunctival staining vs. a sham collagen plug among patients with aqueous-deficient dry eye, although it may increase IOP, research showed.

CHICAGO — In this video, an expert at NUTRITION discusses ongoing research investigating the role of the gut microbiota in nutrition and inflammation.

CHICAGO — Just 10 minutes of daily moderate exercise may lower inflammation and, subsequently, risk for disease, according to research from the annual NUTRITION meeting.

Topline results from the phase 2b RELIEF trial demonstrate that licaminlimab has the potential to reshape the treatment paradigm of dry eye disease, offering a more precise strategy than current methods.

The European Commission announced approval of dupilumab for treating adults with uncontrolled COPD with type 2 inflammation, according to a press release from Regeneron.

FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.